Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin versus norepinephrine for post-CABG refractory hypotension
PACTR201705002221230Recruiting
- Sponsor
- Ahmed Mostafa El-Shaarawy
- Start
- Mar 2017
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Open-label trial of terlipressin and norepinephrine in hypotension (2 arms), sponsored by Ahmed Mostafa El-Shaarawy. Primary endpoint: Correction of hypotension. Started Mar 2017; status: recruiting.
02
Drugs
terlipressinnorepinephrine
03
Conditions
hypotension
Beyond the preview
Go deeper on PACTR201705002221230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201705002221230.